• Profile
Close

Effect of combined testing of ceramides with high-sensitive troponin T on the detection of acute coronary syndrome in patients with chest pain in China: A prospective observational study

BMJ Open Jul 31, 2019

Yao K, Wang Y, Xu D, et al. – Via conducting a prospective observational survey involving 2,773 individuals with chest pain from 4 hospitals in Shanghai, China, between August 2016 and October 2017, experts examined the potential diagnostic value of ceramides for acute coronary syndrome (ACS) in Chinese patients with chest pain. Plasma levels of 12 ceramide molecules and corresponding ratios were contrasted amongst patients with ACS and patients without ACS. Following adjustment of traditional risk factors and high-sensitive cardiac troponin T, independent predictors of ACS were Cer(d18:1/24:1(15Z))/Cer(d18:1/24:0) ratio, Cer(d18:1/14:0) and Cer(d18:1/22:0). A marked improvement in detecting ACS in the multivariable model with ceramides in comparison with those without was demonstrated by receiver operating characteristic curve evaluation. Hence, among patients with chest pain, distinct plasma ceramides were concluded to be independent diagnostic predictors of ACS. In distinguishing ACS among patients with chest pain, ceramides together with high-sensitive troponin and traditional factors exhibited great potential.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay